NYSE:ALUR Allurion Technologies (ALUR) Stock Price, News & Analysis → Collect 10%+ Dividends from AI's Explosive Growth? (From The Oxford Club) (Ad) Free ALUR Stock Alerts $1.23 -0.16 (-11.51%) (As of 06/14/2024 ET) Add Compare Share Share Today's Range$1.20▼$1.3850-Day Range$1.14▼$2.3952-Week Range$1.04▼$9.00Volume47,550 shsAverage Volume580,857 shsMarket Capitalization$58.98 millionP/E RatioN/ADividend YieldN/APrice Target$5.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Allurion Technologies alerts: Email Address Allurion Technologies MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside306.5% Upside$5.00 Price TargetShort InterestHealthy1.91% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.65) to ($0.48) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.60 out of 5 starsMedical Sector683rd out of 915 stocksSurgical & Medical Instruments Industry81st out of 98 stocks 3.5 Analyst's Opinion Consensus RatingAllurion Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageAllurion Technologies has only been the subject of 1 research reports in the past 90 days.Read more about Allurion Technologies' stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted1.91% of the float of Allurion Technologies has been sold short.Short Interest Ratio / Days to CoverAllurion Technologies has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Allurion Technologies has recently increased by 43.80%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldAllurion Technologies does not currently pay a dividend.Dividend GrowthAllurion Technologies does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ALUR. Previous Next 1.8 News and Social Media Coverage News SentimentAllurion Technologies has a news sentiment score of -0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.89 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Allurion Technologies this week, compared to 1 article on an average week.Search Interest1 people have searched for ALUR on MarketBeat in the last 30 days. MarketBeat Follows2 people have added Allurion Technologies to their MarketBeat watchlist in the last 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Allurion Technologies insiders have not sold or bought any company stock.Percentage Held by Insiders20.00% of the stock of Allurion Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 21.39% of the stock of Allurion Technologies is held by institutions.Read more about Allurion Technologies' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Allurion Technologies are expected to grow in the coming year, from ($0.65) to ($0.48) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Allurion Technologies is -0.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Allurion Technologies is -0.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Allurion Technologies' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad The Oxford ClubCollect 10%+ Dividends from AI's Explosive Growth?What if I told you there was a way to collect double-digit income from the AI revolution... Without having to buy a single stock?Click here now to claim your FREE copy of Marc's AI playbook. About Allurion Technologies Stock (NYSE:ALUR)Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.Read More ALUR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ALUR Stock News HeadlinesJune 7, 2024 | americanbankingnews.comAllurion Technologies (NYSE:ALUR) versus MiMedx Group (NASDAQ:MDXG) Critical AnalysisJune 7, 2024 | americanbankingnews.comFinancial Analysis: Allurion Technologies (ALUR) and Its RivalsJune 5, 2024 | businesswire.comAllurion Announces the Appointment of Ojas A. Buch as Chief Operating OfficerMay 30, 2024 | businesswire.comAllurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1sMay 29, 2024 | businesswire.comAllurion to Participate in Two Upcoming Investor Conferences in June 2024May 17, 2024 | finance.yahoo.comAllurion Technologies Inc. (ALUR)May 16, 2024 | insidermonkey.comAllurion Technologies Inc. (NYSE:ALUR) Q1 2024 Earnings Call TranscriptMay 15, 2024 | businesswire.comAllurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight LossMay 14, 2024 | msn.comAllurion Technologies GAAP EPS of $0.11, revenue of $9.4M beats by $0.4MMay 14, 2024 | investorplace.comALUR Stock Earnings: Allurion Technologies Beats EPS, Beats Revenue for Q1 2024May 14, 2024 | businesswire.comAllurion Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 4, 2024 | markets.businessinsider.comAllurion Technologies Inc Registered Shs hosts conference call for investorsMay 2, 2024 | businesswire.comAllurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance SurveyApril 30, 2024 | finance.yahoo.comAllurion Announces Preliminary First Quarter 2024 ResultsApril 18, 2024 | investing.comAllurion secures $48 million in convertible note financingApril 17, 2024 | finance.yahoo.comAllurion Closes $48 Million Convertible Senior Secured Note Financing with RTW InvestmentsApril 17, 2024 | businesswire.comAllurion Closes $48 Million Convertible Senior Secured Note Financing with RTW InvestmentsApril 4, 2024 | marketwatch.comAllurion Technologies Shares Surge 72% After Expanding Virtual Care to U.S.April 4, 2024 | investorplace.comWhy Is Allurion (ALUR) Stock Up 65% Today?April 4, 2024 | msn.comARCA biopharma, Achilles Therapeutics, MSP Recovery among healthcare moversApril 4, 2024 | benzinga.comNasdaq Surges 1%; ConAgra Brands Posts Upbeat EarningsApril 4, 2024 | msn.comAllurion stock soars 85% on weight-loss product launchApril 4, 2024 | businesswire.comAllurion Expands Virtual Care Suite to the United StatesMarch 30, 2024 | uk.finance.yahoo.comAllurion Technologies Full Year 2023 Earnings: US$2.31 loss per share (vs US$1.51 loss in FY 2022)March 23, 2024 | seekingalpha.comAllurion Technologies Inc. (ALUR) Q4 2023 Earnings Call TranscriptSee More Headlines Receive ALUR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Allurion Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2024Today6/14/2024Next Earnings (Estimated)10/18/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNYSE:ALUR Previous SymbolNYSE:ALUR CUSIPN/A CIK1964979 Webwww.allurion.com Phone508-647-4000FaxN/AEmployees501Year FoundedN/APrice Target and Rating Average Stock Price Target$5.00 High Stock Price Target$5.00 Low Stock Price Target$5.00 Potential Upside/Downside+316.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($3.79) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-80,610,000.00 Net Margins-117.30% Pretax Margin-116.67% Return on EquityN/A Return on Assets-85.06% Debt Debt-to-Equity RatioN/A Current Ratio0.81 Quick Ratio0.72 Sales & Book Value Annual Sales$53.47 million Price / Sales1.08 Cash FlowN/A Price / Cash FlowN/A Book Value($1.48) per share Price / Book-0.81Miscellaneous Outstanding Shares47,950,000Free Float38,358,000Market Cap$57.54 million OptionableOptionable Beta-0.22 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesDr. Shantanu K. Gaur M.D. (Age 37)Co-Founder, CEO, President & Director Comp: $383.86kDr. Samuel G. Levy (Age 41)Co-Founder Mr. Christopher Geberth (Age 53)CFO & Treasurer Comp: $408.95kDr. Ram Chuttani M.D. (Age 64)MD, Chief Medical Officer & Founding Partner Mr. Brendan Michael Gibbons (Age 48)Chief Legal Officer & Corporate Secretary Matt WrightVice President of PeopleMs. Joyce JohnsonSenior Vice President of RA & QAMore ExecutivesKey CompetitorsBeauty HealthNASDAQ:SKINAngioDynamicsNASDAQ:ANGOInovio PharmaceuticalsNASDAQ:INOPulmonxNASDAQ:LUNGUtah Medical ProductsNASDAQ:UTMDView All Competitors ALUR Stock Analysis - Frequently Asked Questions Should I buy or sell Allurion Technologies stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Allurion Technologies in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ALUR shares. View ALUR analyst ratings or view top-rated stocks. What is Allurion Technologies' stock price target for 2024? 2 brokerages have issued 1 year price targets for Allurion Technologies' shares. Their ALUR share price targets range from $5.00 to $5.00. On average, they expect the company's stock price to reach $5.00 in the next twelve months. This suggests a possible upside of 306.5% from the stock's current price. View analysts price targets for ALUR or view top-rated stocks among Wall Street analysts. How have ALUR shares performed in 2024? Allurion Technologies' stock was trading at $3.74 at the start of the year. Since then, ALUR stock has decreased by 67.1% and is now trading at $1.23. View the best growth stocks for 2024 here. Are investors shorting Allurion Technologies? Allurion Technologies saw a increase in short interest in the month of May. As of May 31st, there was short interest totaling 594,200 shares, an increase of 43.8% from the May 15th total of 413,200 shares. Based on an average trading volume of 1,000,000 shares, the short-interest ratio is presently 0.6 days. Approximately 1.9% of the shares of the company are short sold. View Allurion Technologies' Short Interest. When is Allurion Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, October 18th 2024. View our ALUR earnings forecast. How were Allurion Technologies' earnings last quarter? Allurion Technologies Inc. (NYSE:ALUR) posted its earnings results on Tuesday, May, 14th. The company reported $0.11 earnings per share for the quarter. The firm had revenue of $9.39 million for the quarter. What guidance has Allurion Technologies issued on next quarter's earnings? Allurion Technologies issued an update on its FY 2024 earnings guidance on Tuesday, May, 14th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $60.0 million-$65.0 million, compared to the consensus revenue estimate of $52.0 million. Who are Allurion Technologies' major shareholders? Allurion Technologies' stock is owned by many different retail and institutional investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%). How do I buy shares of Allurion Technologies? Shares of ALUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:ALUR) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersPresident KamalaThe sneaky (yet 100% legal) way for Obama to return to power The ONLY way Democrats can keep the White Hous...Stansberry Research | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredTime is Running Out - June 25th Deadline Approaching!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRIL...Paradigm Press | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredCollect 10%+ Dividends from AI's Explosive Growth?What if I told you there was a way to collect double-digit income from the AI revolution... Without having ...The Oxford Club | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allurion Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allurion Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.